SDMHF
Sartorius Stedim Biotech S.A. OTC$181.00
Mkt Cap $17.6B
52w Low $178.30
3.1% of range
52w High $264.30
50d MA $199.61
200d MA $217.96
P/E (TTM)
66.3x
EV/EBITDA
26.9x
P/B
4.3x
Debt/Equity
0.7x
ROE
6.6%
P/FCF
140.2x
RSI (14)
—
ATR (14)
—
Beta
1.17
50d MA
$199.61
200d MA
$217.96
Avg Volume
2.5K
About
Sartorius Stedim Biotech S.A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological p…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | AMC | 1.40 | 1.35 | -3.6% | 187.00 | +1.1% | +1.1% | +1.1% | -1.5% | -3.7% | -3.2% | — |
| Feb 16, 2026 | AMC | 1.48 | 1.32 | -10.8% | — | — | — | — | — | — | — | — |
| Oct 16, 2025 | AMC | 1.15 | 0.91 | -21.1% | 219.50 | +0.0% | +0.0% | +8.4% | +12.3% | +12.3% | +12.3% | — |
| Jul 22, 2025 | AMC | 1.22 | 0.81 | -33.4% | 206.95 | +0.0% | -0.9% | +0.7% | +0.7% | -0.5% | -0.5% | — |
| Apr 16, 2025 | AMC | 1.02 | 0.96 | -5.4% | 214.00 | +1.9% | +1.9% | +1.9% | +1.9% | +1.9% | +1.9% | — |
| Jan 28, 2025 | AMC | 0.98 | 0.49 | -50.3% | 213.10 | +9.7% | +9.5% | +11.0% | +11.0% | +11.0% | +11.0% | — |
| Oct 17, 2024 | AMC | 0.89 | 0.29 | -67.6% | 221.50 | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | -5.9% | — |
| Jul 18, 2024 | AMC | 1.07 | 0.53 | -50.8% | 190.00 | -15.7% | -15.8% | -15.8% | -15.8% | -15.8% | -15.8% | — |
| Apr 18, 2024 | AMC | 0.97 | 0.62 | -35.9% | 225.35 | -5.7% | -5.0% | -5.0% | -0.5% | -0.4% | -0.4% | — |
| Jan 26, 2024 | AMC | 0.88 | 0.47 | -46.2% | 259.00 | +0.0% | +0.0% | -0.1% | -0.1% | +2.1% | +1.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1 | Societe Generale | Downgrade | Buy → Hold | — | $559.95 | $559.95 | +0.0% | +0.0% | -9.2% | -9.5% | -5.4% | -5.4% |
Data updated apr 28, 2026 8:36pm
· Source: massive.com